vs

ALLIANCE RESOURCE PARTNERS LP(ARLP)与Bio-Techne(TECH)财务数据对比。点击上方公司名可切换其他公司

ALLIANCE RESOURCE PARTNERS LP的季度营收约是Bio-Techne的1.7倍($516.0M vs $311.4M),Bio-Techne净利率更高(16.4% vs 2.1%,领先14.3%),Bio-Techne同比增速更快(-1.5% vs -3.6%),过去两年Bio-Techne的营收复合增速更高(1.3% vs -6.7%)

联合资源伙伴有限合伙是北美领先的自然资源企业,核心业务为公用事业及工业客户生产、销售煤炭,同时运营矿权特许经营、油气开采、物流配套等关联业务,服务覆盖美国及周边主要能源消费市场。

Bio-Techne是美国头部生命科学企业,面向科研、诊断及生物工艺市场需求,研发、生产并销售生命科学试剂、仪器及配套服务,产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景,可为相关领域从业者提供可靠的专业工具支持。

ARLP vs TECH — 直观对比

营收规模更大
ARLP
ARLP
是对方的1.7倍
ARLP
$516.0M
$311.4M
TECH
营收增速更快
TECH
TECH
高出2.1%
TECH
-1.5%
-3.6%
ARLP
净利率更高
TECH
TECH
高出14.3%
TECH
16.4%
2.1%
ARLP
两年增速更快
TECH
TECH
近两年复合增速
TECH
1.3%
-6.7%
ARLP

损益表 — Q1 FY2026 vs Q3 FY2026

指标
ARLP
ARLP
TECH
TECH
营收
$516.0M
$311.4M
净利润
$10.7M
$51.0M
毛利率
66.9%
营业利润率
4.2%
24.2%
净利率
2.1%
16.4%
营收同比
-3.6%
-1.5%
净利润同比
126.0%
每股收益(稀释后)
$0.32

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
ARLP
ARLP
TECH
TECH
Q1 26
$516.0M
$311.4M
Q4 25
$535.5M
$295.9M
Q3 25
$571.4M
Q2 25
$547.5M
$317.0M
Q1 25
$540.5M
$316.2M
Q4 24
$590.1M
$297.0M
Q3 24
$613.6M
$289.5M
Q2 24
$593.4M
$306.1M
净利润
ARLP
ARLP
TECH
TECH
Q1 26
$10.7M
$51.0M
Q4 25
$82.7M
$38.0M
Q3 25
$95.1M
Q2 25
$59.4M
$-17.7M
Q1 25
$74.0M
$22.6M
Q4 24
$16.3M
$34.9M
Q3 24
$86.3M
$33.6M
Q2 24
$100.2M
$40.6M
毛利率
ARLP
ARLP
TECH
TECH
Q1 26
66.9%
Q4 25
64.6%
Q3 25
Q2 25
62.7%
Q1 25
67.9%
Q4 24
65.3%
Q3 24
63.2%
Q2 24
66.4%
营业利润率
ARLP
ARLP
TECH
TECH
Q1 26
4.2%
24.2%
Q4 25
18.2%
18.4%
Q3 25
18.4%
Q2 25
16.2%
-7.5%
Q1 25
17.4%
12.2%
Q4 24
2.6%
16.0%
Q3 24
16.5%
13.8%
Q2 24
19.8%
15.0%
净利率
ARLP
ARLP
TECH
TECH
Q1 26
2.1%
16.4%
Q4 25
15.4%
12.8%
Q3 25
16.6%
Q2 25
10.9%
-5.6%
Q1 25
13.7%
7.1%
Q4 24
2.8%
11.7%
Q3 24
14.1%
11.6%
Q2 24
16.9%
13.3%
每股收益(稀释后)
ARLP
ARLP
TECH
TECH
Q1 26
$0.32
Q4 25
$0.24
Q3 25
Q2 25
$-0.11
Q1 25
$0.14
Q4 24
$0.22
Q3 24
$0.21
Q2 24
$0.26

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
ARLP
ARLP
TECH
TECH
现金及短期投资手头流动性
$28.9M
$209.8M
总债务越低越好
股东权益账面价值
$2.1B
总资产
$2.9B
$2.6B
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
ARLP
ARLP
TECH
TECH
Q1 26
$28.9M
$209.8M
Q4 25
$71.2M
$172.9M
Q3 25
$94.5M
Q2 25
$55.0M
$162.2M
Q1 25
$81.3M
$140.7M
Q4 24
$137.0M
$177.5M
Q3 24
$195.4M
$187.5M
Q2 24
$203.7M
$152.9M
总债务
ARLP
ARLP
TECH
TECH
Q1 26
Q4 25
$260.0M
Q3 25
Q2 25
$346.0M
Q1 25
$330.0M
Q4 24
$300.0M
Q3 24
$300.0M
Q2 24
$319.0M
股东权益
ARLP
ARLP
TECH
TECH
Q1 26
$2.1B
Q4 25
$2.0B
Q3 25
Q2 25
$1.9B
Q1 25
$2.0B
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$2.1B
总资产
ARLP
ARLP
TECH
TECH
Q1 26
$2.9B
$2.6B
Q4 25
$2.9B
$2.5B
Q3 25
$2.9B
Q2 25
$2.9B
$2.6B
Q1 25
$2.9B
$2.6B
Q4 24
$2.9B
$2.7B
Q3 24
$3.0B
$2.7B
Q2 24
$3.1B
$2.7B
负债/权益比
ARLP
ARLP
TECH
TECH
Q1 26
Q4 25
0.13×
Q3 25
Q2 25
0.18×
Q1 25
0.16×
Q4 24
0.14×
Q3 24
0.14×
Q2 24
0.15×

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
ARLP
ARLP
TECH
TECH
经营现金流最新季度
自由现金流经营现金流 - 资本支出
$13.3M
自由现金流率自由现金流/营收
2.6%
资本支出强度资本支出/营收
18.5%
现金转化率经营现金流/净利润
过去12个月自由现金流最近4个季度
$342.2M

8季度趋势,按日历期对齐

经营现金流
ARLP
ARLP
TECH
TECH
Q1 26
Q4 25
$143.9M
Q3 25
$209.9M
Q2 25
$151.7M
$98.2M
Q1 25
$145.7M
$41.1M
Q4 24
$168.4M
$84.3M
Q3 24
$209.3M
$63.9M
Q2 24
$215.8M
$75.5M
自由现金流
ARLP
ARLP
TECH
TECH
Q1 26
$13.3M
Q4 25
$99.1M
Q3 25
$145.2M
Q2 25
$84.7M
$93.3M
Q1 25
$58.9M
$31.0M
Q4 24
$75.3M
$77.5M
Q3 24
$99.0M
$54.7M
Q2 24
$114.3M
$57.5M
自由现金流率
ARLP
ARLP
TECH
TECH
Q1 26
2.6%
Q4 25
18.5%
Q3 25
25.4%
Q2 25
15.5%
29.4%
Q1 25
10.9%
9.8%
Q4 24
12.8%
26.1%
Q3 24
16.1%
18.9%
Q2 24
19.3%
18.8%
资本支出强度
ARLP
ARLP
TECH
TECH
Q1 26
18.5%
Q4 25
8.4%
Q3 25
11.3%
Q2 25
12.2%
1.5%
Q1 25
16.1%
3.2%
Q4 24
15.8%
2.3%
Q3 24
18.0%
3.2%
Q2 24
17.1%
5.9%
现金转化率
ARLP
ARLP
TECH
TECH
Q1 26
Q4 25
1.74×
Q3 25
2.21×
Q2 25
2.55×
Q1 25
1.97×
1.82×
Q4 24
10.31×
2.42×
Q3 24
2.43×
1.90×
Q2 24
2.15×
1.86×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

ARLP
ARLP

Coal sales$443.3M86%
Oil & gas royalties$41.3M8%
Other revenues$22.8M4%
Transportation revenues$8.6M2%
Tons Produced$8.0M2%
Mineral Interest Volumes (BOE)$1.0M0%

TECH
TECH

Protein Sciences segment revenue$226.2M73%
Diagnostics and Spatial Biology segment revenue$85.6M27%
Other revenue (1)$5.4M2%

相关对比